Literature DB >> 10732809

Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity.

M A Pericak-Vance1, M C Speer, F Lennon, S G West, M M Menold, J M Stajich, C M Wolpert, B D Slotterbeck, M Saito, R W Tim, M P Rozear, L T Middleton, S Tsuji, J M Vance.   

Abstract

The Charcot-Marie-Tooth (CMT) neuropathies are a group of disorders exhibiting neurophysical, pathological and genetic heterogeneity. CMT2 is a diagnostic subtype of this group of disorders characterized by variable expression and age-of-onset and normal or slightly diminished nerve conduction velocities. Previously, linkage and heterogeneity had been reported in CMT2 with linked families localizing to chromosome 1p (CMT2A). Recently a second CMT2 locus has been described on chromosome 7 in a single large CMT2 family (CMT2D). We have performed pedigree linkage analysis on 15 CMT2 families (N = 371 individuals, 106 affected family members) and have confirmed linkage to chromosome 7. Furthermore, using both admixture and multipoint linkage analysis we show conclusive evidence for additional heterogeneity within this clinical subtype with evidence of families that exclude linkage to both the CMT2D and CMT2A regions. In addition, unlike the previous report we found no obvious consistent clinical differences between the linked family types.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10732809     DOI: 10.1007/s100480050013

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  6 in total

1.  Linkage analyses in Caribbean Hispanic families identify novel loci associated with familial late-onset Alzheimer's disease.

Authors:  Sandra Barral; Rong Cheng; Christiane Reitz; Badri Vardarajan; Joseph Lee; Brian Kunkle; Gary Beecham; Laura S Cantwell; Margaret A Pericak-Vance; Lindsay A Farrer; Jonathan L Haines; Alison M Goate; Tatiana Foroud; Eric Boerwinkle; Gerard D Schellenberg; Richard Mayeux
Journal:  Alzheimers Dement       Date:  2015-10-01       Impact factor: 21.566

Review 2.  Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.

Authors:  Stephanie N Oprescu; Laurie B Griffin; Asim A Beg; Anthony Antonellis
Journal:  Methods       Date:  2016-11-20       Impact factor: 3.608

3.  The CMT2D locus: refined genetic position and construction of a bacterial clone-based physical map.

Authors:  R E Ellsworth; V Ionasescu; C Searby; V C Sheffield; V V Braden; T A Kucaba; J D McPherson; M A Marra; E D Green
Journal:  Genome Res       Date:  1999-06       Impact factor: 9.043

4.  Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V.

Authors:  Anthony Antonellis; Rachel E Ellsworth; Nyamkhishig Sambuughin; Imke Puls; Annette Abel; Shih-Queen Lee-Lin; Albena Jordanova; Ivo Kremensky; Kyproula Christodoulou; Lefkos T Middleton; Kumaraswamy Sivakumar; Victor Ionasescu; Benoit Funalot; Jeffery M Vance; Lev G Goldfarb; Kenneth H Fischbeck; Eric D Green
Journal:  Am J Hum Genet       Date:  2003-04-10       Impact factor: 11.025

5.  Dominant intermediate Charcot-Marie-Tooth type C maps to chromosome 1p34-p35.

Authors:  Albena Jordanova; Florian P Thomas; Velina Guergueltcheva; Ivailo Tournev; Francisco A A Gondim; Borjana Ishpekova; Els De Vriendt; An Jacobs; Ivan Litvinenko; Neviana Ivanova; Borjan Buzhov; Peter De Jonghe; Ivo Kremensky; Vincent Timmerman
Journal:  Am J Hum Genet       Date:  2003-11-06       Impact factor: 11.025

6.  Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.

Authors:  Laurie B Griffin; Reiko Sakaguchi; David McGuigan; Michael A Gonzalez; Charles Searby; Stephan Züchner; Ya-Ming Hou; Anthony Antonellis
Journal:  Hum Mutat       Date:  2014-11       Impact factor: 4.878

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.